| Prevention of HIV-1 infection with early antiretroviral therapy HS Team. N Engl J Med 365 (6), 493-505, 2011 | 8748* | 2011 |
| Antiretroviral prophylaxis for HIV prevention in heterosexual men and women JM Baeten, D Donnell, P Ndase, NR Mugo, JD Campbell, J Wangisi, ... New England journal of medicine 367 (5), 399-410, 2012 | 3743 | 2012 |
| Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana MC Thigpen, PM Kebaabetswe, LA Paxton, DK Smith, CE Rose, ... New England journal of medicine 367 (5), 423-434, 2012 | 2380 | 2012 |
| Antiretroviral Therapy for the Prevention of HIV-1 Transmission HS Team. N Engl J Med 375 (9), 830-9, 2016 | 1825* | 2016 |
| Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 … K Choopanya, M Martin, P Suntharasamai, U Sangkum, PA Mock, ... The Lancet 381 (9883), 2083-2090, 2013 | 1640 | 2013 |
| Tenofovir-based preexposure prophylaxis for HIV infection among African women JM Marrazzo, G Ramjee, BA Richardson, K Gomez, N Mgodi, G Nair, ... New England Journal of Medicine 372 (6), 509-518, 2015 | 1470 | 2015 |
| Use of a vaginal ring containing dapivirine for HIV-1 prevention in women JM Baeten, T Palanee-Phillips, ER Brown, K Schwartz, LE Soto-Torres, ... New England Journal of Medicine 375 (22), 2121-2132, 2016 | 856 | 2016 |
| Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers CW Hendrix, C Flexner, RT MacFarland, C Giandomenico, EJ Fuchs, ... Antimicrobial agents and chemotherapy 44 (6), 1667-1673, 2000 | 666 | 2000 |
| Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. M Clerici, FT Hakim, DJ Venzon, S Blatt, CW Hendrix, TA Wynn, ... The Journal of clinical investigation 91 (3), 759-765, 1993 | 587 | 1993 |
| Platelet GP IIIa PlA Polymorphisms Display Different Sensitivities to Agonists AD Michelson, MI Furman, P Goldschmidt-Clermont, MA Mascelli, ... Circulation 101 (9), 1013-1018, 2000 | 492 | 2000 |
| Cabotegravir for HIV prevention in cisgender men and transgender women RJ Landovitz, D Donnell, ME Clement, B Hanscom, L Cottle, L Coelho, ... New England Journal of Medicine 385 (7), 595-608, 2021 | 474 | 2021 |
| Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro M Clerici, DR Lucey, JA Berzofsky, LA Pinto, TA Wynn, SP Blatt, MJ Dolan, ... Science 262 (5140), 1721-1724, 1993 | 471 | 1993 |
| Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit JB Dimick, RK Pelz, R Consunji, SM Swoboda, CW Hendrix, PA Lipsett Archives of Surgery 136 (2), 229-234, 2001 | 464 | 2001 |
| Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. M Clerici, TA Wynn, JA Berzofsky, SP Blatt, CW Hendrix, A Sher, ... The Journal of clinical investigation 93 (2), 768-775, 1994 | 456 | 1994 |
| Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection CW Hendrix, AC Collier, MM Lederman, D Schols, RB Pollard, S Brown, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 37 (2), 1253-1262, 2004 | 453 | 2004 |
| Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients RK Pelz, CW Hendrix, SM Swoboda, M Diener-West, WG Merz, ... Annals of surgery 233 (4), 542-548, 2001 | 386 | 2001 |
| HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention D Donnell, JM Baeten, NN Bumpus, J Brantley, DR Bangsberg, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 66 (3), 340-348, 2014 | 377 | 2014 |
| Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis. M Clerici, A Sarin, RL Coffman, TA Wynn, SP Blatt, CW Hendrix, SF Wolf, ... Proceedings of the National Academy of Sciences 91 (25), 11811-11815, 1994 | 271 | 1994 |
| Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial S Delany-Moretlwe, JP Hughes, P Bock, SG Ouma, P Hunidzarira, ... The Lancet 399 (10337), 1779-1789, 2022 | 251 | 2022 |
| Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women KH Mayer, LA Maslankowski, F Gai, WM El-Sadr, J Justman, A Kwiecien, ... Aids 20 (4), 543-551, 2006 | 225 | 2006 |
Mark MarzinkeProfessor, Johns Hopkins University School of MedicineVerified email at jhmi.edu
